Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Cardiovascular Diseases × zanubrutinib × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Lymphoma, Mantle-Cell 4 Lymphoma, Large B-Cell, Diffuse 4 Waldenstrom Macroglobulinemia 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Lymphoma, Non-Hodgkin 2 Recurrence 1 Multiple Myeloma 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Lymphoma 1 Intraocular Lymphoma 1 Cardiovascular Diseases 1

Interventions

zanubrutinib 1 acalabrutinib 1 Melatonin 1 Ethanol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07283965 2025-12-16

Zanubrutinib and Acalabrutinib Use and Risk of Atrial Fibrillation in Patients With Chronic B-cell Malignancies

University Hospital, Caen

Not yet recruiting

15,000 enrolled

Cardiovascular Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡